DNA biosynthesis discovery could lead to better antibiotics

Apr 16, 2009
This is a cartoon diagram of an enzyme, an example of the class of FDTS enzymes. Credit: Amnon Kohen, University of Iowa

Combating several human pathogens, including some biological warfare agents, may one day become a bit easier thanks to research reported by a University of Iowa chemist and his colleagues in the April 16 issue of the journal Nature.

Amnon Kohen, associate professor of chemistry in the UI College of Liberal Arts and Sciences, said that the study indicated a new mechanism by which certain organisms manufacture the DNA base thymidylate. This new mechanism is so very different from the way humans synthesize this base that drugs targeting this biosynthetic path in the pathogens are unlikely to affect the human path, thus resulting in very reduced side effects or no side effects at all.

Kohen suggested that the process is similar to feeding the "bad bugs" a poison that your own body's cells don't eat.

"The study proposes a new catalytic mechanism for DNA biosynthesis in organisms that contain the gene thyX, including several human pathogens," he said. "This mechanism is very different from the mechanism of biosynthesis and may involve unique chemical aspects not yet reported in enzyme catalysis."

He added that the enzyme being studied is present in pathogens causing anthrax, tuberculosis, botulism, syphilis, pneumonia, and other human diseases.

"Technically speaking, the newly proposed catalyst mechanism is the first example of thymidylate biosynthesis that occurs without an enzymatic nucleophile," he said.

Kohen explained that in the past, it was assumed that the combined action of two enzymes (thymidylate synthase - Tsase and dihydrofolate reductase - DHFR) is essential for in all organisms. Then, in 2002, Ursula Liebl and Hannu Myllykallio from Ecole Polytechnique, France, found that many organisms lack the gene coding for these two critical enzymes. They identified a new class of enzymes, coded by a very different gene (thyX) that had the combined activities of both classical enzymes.

This enzyme is called flavin-dependent thymidylate synthase (FDTS), because -- in contrast to the classical enzymes -- it requires the yellow co-factor flavin to function. It was originally assumed that the catalytic mechanism of FDTS is similar to that of the classical enzymes, but the fact that drugs that inhibit these enzymes do not inhibit FDTS and other unusual phenomena caught Kohen's attention, and his group began to study its mechanism in 2004. (Researchers in Kohen's group who were involved in the earlier stages of this study include Nitish Agrawal, Anatoly Chernyshev, and Zhen Wang.)

The research team used a combination of methodologies from various scientific fields -- such as molecular biology, structural biology, biochemistry, and physical and organic chemistry -- to elucidate the mechanism of this recently discovered enzyme.

Said Kohen: "Our findings indicate that the mechanism of this new FDTS is completely and substantially different from that of either DHFR or TSase, and may involve chemistry that was not previously identified in biological systems. Since humans don't have this enzyme and since it is essential in several human pathogens, it is now the goal of the research community to develop drugs that target this enzyme, as such drugs are not likely to affect humans and thus may have reduced toxicity.

"Since this biosynthetic path has not been targeted before by antibiotics, there is a hope that drugs that will target FDTS will be efficient against pathogens with multiple drug resistance, like several strains of tuberculosis," he said.

Source: University of Iowa (news : web)

Explore further: Color-coading gene sequences in human cells

add to favorites email to friend print save as pdf

Related Stories

Vitamin B1 biosynthesis: Think Rubik's cube

Nov 20, 2008

(PhysOrg.com) -- A key enzyme in the biosynthesis of vitamin B1 has somehow evolved the ability to perform a complex series of some 15 to 20 steps, report two Cornell chemists.

Pieces of Catalyst Puzzle Explained

Jun 05, 2007

Catalysts speed up chemical reactions, as in your car’s catalytic converter, and they even double as clichés, as in “catalyst for change,” but how they work remains a mystery.

Recommended for you

Color-coading gene sequences in human cells

20 hours ago

(Phys.org)—Is there a way to peer inside the nucleus of a living cell and see how the genes interact? After the completion of the Human Genome Project in 2001, researchers have focused on epigenetic factors, ...

The origins of polarized nervous systems

Mar 03, 2015

(Phys.org)—There is no mistaking the first action potential you ever fired. It was the one that blocked all the other sperm from stealing your egg. After that, your spikes only got more interesting. Waves ...

New fat cells created quickly, but they don't disappear

Mar 03, 2015

Once fat cells form, they might shrink during weight loss, but they do not disappear, a fact that has derailed many a diet. Yale researchers in the March 2 issue of the journal Nature Cell Biology descri ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.